Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke "Heparinas"


Phase 4 Results N/A

Summary of Purpose

The goal of this study is to show the efficacy and safety of heparin and nadroparin in the acute phase of ischemic stroke. Therapeutic agents are administered at intervals of 4.5 to 2 hours after onset of clinical signs. Overall administration of anticoagulant agents will test 72 hours. Randomized patients will be divided into three groups. The first group of patients will receive heparin intravenously at...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 14 August 2013.

1 May 2013 20 May 2013 1 May 2015 1 Dec 2015 1 Aug 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment